By Kim Richters
Merck KGaA said late Tuesday that it has acquired Lonza Group AG's automated bioreactor sampling system, MAST.
The German pharmaceuticals-and-chemicals company didn't disclose financial terms of the deal.
"Today, biopharmaceutical companies are under immense pressure to get products to patients faster," Andrew Bulpin, head of process solutions at Merck KGaA's life-science business sector, said.
"The acquisition of the MAST platform adds fully automated sampling to our bioprocessing portfolio."
Write to Kim Richters at email@example.com
(END) Dow Jones Newswires
April 06, 2022 01:34 ET (05:34 GMT)Copyright (c) 2022 Dow Jones & Company, Inc.